• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有流感血凝素结合肽的外围功能化碳硅烷树状大分子的合成及抗流感病毒活性。

Synthesis and influenza virus inhibitory activities of carbosilane dendrimers peripherally functionalized with hemagglutinin-binding Peptide.

机构信息

Division of Materials Science, Graduate School of Science and Technology, Saitama University , 255 Shimo-Ohkubo, Sakura-ku, Saitama 338-8570, Japan.

出版信息

J Med Chem. 2014 Oct 23;57(20):8332-9. doi: 10.1021/jm5007676. Epub 2014 Oct 6.

DOI:10.1021/jm5007676
PMID:25249262
Abstract

A series of carbosilane dendrimers uniformly functionalized with hemagglutinin (HA) binding peptide (sialic acid-mimic peptide, Ala-Arg-Leu-Pro-Arg) was systematically synthesized, and their anti-influenza virus activity was evaluated. The carbosilane-based peptide dendrimers, unlike sialylated dendrimers, cannot be digested by virus neuraminidases. The peptide dendrimers exhibited intriguing biological activities depending on the form of their core frame, with a dumbbell-type peptide dendrimer showing particularly strong inhibitory activities against two human influenza viruses, A/PR/8/34 (H1N1) and A/Aichi/2/68 (H3N2). The IC50 values of the dumbbell-type peptide dendrimer for both strains were 0.60 μM, the highest activity among the HA-binding peptide derivatives. The results suggest that a dumbbell-shaped carbosilane dendrimer is the most suitable core scaffold for HA-binding peptide dendrimers.

摘要

一系列均匀官能化的血凝集素(HA)结合肽(唾液酸模拟肽,Ala-Arg-Leu-Pro-Arg)的碳硅烷树状大分子被系统地合成,并评估了它们的抗流感病毒活性。与唾液酸化的树状大分子不同,基于碳硅烷的肽树状大分子不能被病毒神经氨酸酶消化。肽树状大分子表现出有趣的生物学活性,这取决于它们的核心框架的形式,哑铃型肽树状大分子对两种人类流感病毒 A/PR/8/34(H1N1)和 A/Aichi/2/68(H3N2)表现出特别强的抑制活性。哑铃型肽树状大分子对两种菌株的 IC50 值均为 0.60 μM,是 HA 结合肽衍生物中活性最高的。结果表明,哑铃形碳硅烷树状大分子是最适合 HA 结合肽树状大分子的核心支架。

相似文献

1
Synthesis and influenza virus inhibitory activities of carbosilane dendrimers peripherally functionalized with hemagglutinin-binding Peptide.具有流感血凝素结合肽的外围功能化碳硅烷树状大分子的合成及抗流感病毒活性。
J Med Chem. 2014 Oct 23;57(20):8332-9. doi: 10.1021/jm5007676. Epub 2014 Oct 6.
2
Syntheses and biological evaluations of carbosilane dendrimers uniformly functionalized with sialyl alpha(2-->3) lactose moieties as inhibitors for human influenza viruses.以唾液酸α(2→3)乳糖部分均匀官能化的碳硅烷树枝状大分子作为人类流感病毒抑制剂的合成与生物学评价
Bioorg Med Chem. 2009 Aug 1;17(15):5465-75. doi: 10.1016/j.bmc.2009.06.035. Epub 2009 Jun 21.
3
Sialyl alpha(2-->3) lactose clusters using carbosilane dendrimer core scaffolds as influenza hemagglutinin blockers.使用碳硅烷树枝状大分子核心支架作为流感血凝素阻滞剂的唾液酸α(2→3)乳糖簇
Bioorg Med Chem Lett. 2008 Aug 1;18(15):4405-8. doi: 10.1016/j.bmcl.2008.06.101. Epub 2008 Jul 3.
4
Systematic syntheses of influenza neuraminidase inhibitors: a series of carbosilane dendrimers uniformly functionalized with thioglycoside-type sialic acid moieties.流感神经氨酸酶抑制剂的系统合成:一系列用硫代糖苷型唾液酸部分均匀官能化的碳硅烷树枝状大分子。
Bioorg Med Chem. 2009 Aug 1;17(15):5451-64. doi: 10.1016/j.bmc.2009.06.036. Epub 2009 Jun 21.
5
Novel daidzein analogs and their in vitro anti-influenza activities.新型大豆苷元类似物及其体外抗流感活性。
Chem Biodivers. 2015 Apr;12(4):685-96. doi: 10.1002/cbdv.201400337.
6
Carbosilane glycodendrimers.碳硅烷糖树状聚合物。
Chem Soc Rev. 2013 Jun 7;42(11):4574-98. doi: 10.1039/c2cs35421g. Epub 2012 Dec 21.
7
Design, synthesis and biological evaluation of novel L-ascorbic acid-conjugated pentacyclic triterpene derivatives as potential influenza virus entry inhibitors.新型L-抗坏血酸共轭五环三萜衍生物作为潜在流感病毒进入抑制剂的设计、合成及生物学评价
Eur J Med Chem. 2016 Mar 3;110:376-88. doi: 10.1016/j.ejmech.2016.01.005. Epub 2016 Jan 8.
8
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against influenza virus isolates in the 2011-2012 season in Japan.四种神经氨酸酶抑制剂对2011 - 2012年日本流行季流感病毒分离株的体外神经氨酸酶抑制活性。
J Infect Chemother. 2014 Feb;20(2):77-80. doi: 10.1016/j.jiac.2013.07.002. Epub 2013 Dec 11.
9
Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.半合成替考拉宁衍生物作为新型流感病毒结合抑制剂:合成与抗病毒研究
Bioorg Med Chem Lett. 2014 Aug 1;24(15):3251-4. doi: 10.1016/j.bmcl.2014.06.018. Epub 2014 Jun 16.
10
Antiviral activity of baicalin against influenza A (H1N1/H3N2) virus in cell culture and in mice and its inhibition of neuraminidase.黄芩苷在细胞培养和小鼠体内对甲型流感病毒(H1N1/H3N2)的抗病毒活性及其对神经氨酸酶的抑制作用。
Arch Virol. 2014 Dec;159(12):3269-78. doi: 10.1007/s00705-014-2192-2. Epub 2014 Jul 31.

引用本文的文献

1
SARS-CoV-2 Fusion Peptide Conjugated to a Tetravalent Dendrimer Selectively Inhibits Viral Infection.与四价树枝状大分子偶联的新型冠状病毒融合肽可选择性抑制病毒感染。
Pharmaceutics. 2023 Dec 17;15(12):2791. doi: 10.3390/pharmaceutics15122791.
2
Antiviral Peptides as Anti-Influenza Agents.抗病毒肽作为抗流感药物。
Int J Mol Sci. 2022 Sep 28;23(19):11433. doi: 10.3390/ijms231911433.
3
Ramified derivatives of 5-(perylen-3-ylethynyl)uracil-1-acetic acid and their antiviral properties.5-(苝-3-基乙炔基)尿嘧啶-1-乙酸的分支衍生物及其抗病毒特性。
RSC Adv. 2019 Aug 20;9(45):26014-26023. doi: 10.1039/c9ra06313g. eCollection 2019 Aug 19.
4
Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides.作为成功的抗 HIV-1 阴道杀微生物剂,在阴离子树状聚合物的临床前开发中,基线和时间更新因素。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022 May;14(3):e1774. doi: 10.1002/wnan.1774. Epub 2022 Jan 12.
5
Developments in Treatment Methodologies Using Dendrimers for Infectious Diseases.树状高分子在传染病治疗方法中的应用进展。
Molecules. 2021 May 31;26(11):3304. doi: 10.3390/molecules26113304.
6
Human respiratory viral infections: Current status and future prospects of nanotechnology-based approaches for prophylaxis and treatment.人类呼吸道病毒感染:基于纳米技术的预防和治疗方法的现状与未来前景
Life Sci. 2021 Aug 1;278:119561. doi: 10.1016/j.lfs.2021.119561. Epub 2021 Apr 26.
7
Peptides and Dendrimers: How to Combat Viral and Bacterial Infections.肽与树枝状大分子:如何对抗病毒和细菌感染。
Pharmaceutics. 2021 Jan 14;13(1):101. doi: 10.3390/pharmaceutics13010101.
8
Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections.基于纳米技术的药物输送系统在抗病毒感染方面的最新进展。
AAPS PharmSciTech. 2021 Jan 14;22(1):47. doi: 10.1208/s12249-020-01908-5.
9
Peptides to combat viral infectious diseases.肽类药物抗击病毒传染病。
Peptides. 2020 Dec;134:170402. doi: 10.1016/j.peptides.2020.170402. Epub 2020 Sep 1.
10
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases.寡核苷酸疗法:慢性炎症性呼吸疾病药物传递的新兴重点领域。
Chem Biol Interact. 2019 Aug 1;308:206-215. doi: 10.1016/j.cbi.2019.05.028. Epub 2019 May 25.